Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30018472HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043783HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043784HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043785HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043786HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043787HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043788HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043789HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043790HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043791HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TCGA Plot Options
Drug Information
GeneTOP2A
DrugBank IDDB06013
Drug NameAldoxorubicin
Target IDBE0000742
UniProt IDP11388
Regulation Typeinhibitor
PubMed IDs25312684
CitationsChawla SP, Chua VS, Hendifar AF, Quon DV, Soman N, Sankhala KK, Wieland DS, Levitt DJ: A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma. Cancer. 2015 Feb 15;121(4):570-9. doi: 10.1002/cncr.29081. Epub 2014 Oct 13.
GroupsInvestigational
Direct ClassificationAnthracyclines
SMILESCOC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(CO)=NNC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL2107818